BELLSHILL, SCOTLAND, 25 February 2013: Following its announcement to expand into the Far East last month, certified specialist oligonucleotide reagent manufacturer Link Technologies Ltd, has agreed another distribution contract in Asia with Japanese company GeneDesign, Inc.. The deal comes just a few weeks after the signing of Zirench Technology for distribution in China.
Link Technologies is ISO 9001:2008 certified and manufacture a comprehensive range of reagents for DNA, RNA and PNA synthesis and modifications including a custom service for tailored compounds in specialist applications. GeneDesign, located in Osaka, Japan, will represent Link Technologies throughout Japan and will be exhibiting at the forthcoming AsiaTIDES meeting on oligonucleotide and peptide research, technology and product development on February 26-28 in Tokyo, Japan.
Speaking about the agreement, Hideaki Sato, General Manager, Technical Support and Marketing at GeneDesign, Inc. said “Our collaboration with Link Technologies supports our goal of contributing to human welfare and health through nucleic acid technology development. We are delighted to be working with Link Technologies to increase the presence and usage of their high quality, reliable oligo precursor products in Japan. We invite people to visit us at the AsiaTIDES meeting to discover in detail the many benefits of these new offerings.”
Dr John Bremner, CEO at Link Technologies added “By working with GeneDesign we will be able to provide local access to our high quality products and offer our expert support services to customers throughout Japan. This level of accessibility is something we are very keen to continue to develop within Asia and worldwide, and forms part of our on-going strategic plans for development and growth. GeneDesign is a company that values the importance of this and we look forward to working with them.”
For more information please visit the Link Technologies website at www.linktech.co.uk or follow us on Twitter: @linktechdna.
About Link Technologies Ltd
Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.
Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.
For further information see: www.linktech.co.uk.
About GeneDesign, Inc.
GeneDesign, Inc. is a leading oligonucleotides Contract Manufacturing Organization (CMO) in Japan. The company also operates as an experienced Contract Research Organization (CRO) focused on oligonucleotide chemistry. GeneDesign offers contract manufacturing of various oligonucleotides, including PEGylation and Peptide conjugation, from quantities suitable for screening use up to hundreds of grams, under GMP and sterilized conditions. As such, GeneDesign can contribute to your successful oligo therapeutics and diagnostics development.
GeneDesign have also launched a new oligo-synthesizer particularly suitable for manufacturing long RNA and heavily modified oligonucleotides.
For further information see: www.genedesign.co.jp/e/
